Incyte (INCY) Financials

$66.04 +1.11 (+1.71%)

Closing price 04:00 PM Eastern

Extended Trading

$66.04 +0.00 (+0.01%)

As of 05:44 PM Eastern

Annual Income Statements for Incyte

This table shows Incyte's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	33	598	341	949	-296	447	109	-313	104	6.53
Consolidated Net Income / (Loss)	33	598	341	949	-296	447	109	-313	104	6.53
Net Income / (Loss) Continuing Operations	33	598	341	949	-296	447	109	-313	104	6.53
Total Pre-Tax Income	317	834	529	570	-232	487	115	-312	107	7.56
Total Operating Income	61	621	579	586	-264	402	129	-243	145	51
Total Gross Profit	3,929	3,441	3,188	2,835	2,535	2,045	1,788	1,457	1,048	727
Total Revenue	4,241	3,696	3,395	2,986	2,667	2,159	1,882	1,536	1,106	754
Operating Revenue	4,241	3,696	3,395	2,986	2,667	2,159	1,882	1,536	1,106	754
Total Cost of Revenue	312	255	207	151	131	114	94	79	58	27
Operating Cost of Revenue	312	255	207	151	131	114	94	79	58	27
Total Operating Expenses	3,868	2,820	2,608	2,249	2,799	1,643	1,659	1,700	903	676
Selling, General & Admin Expense	1,242	1,161	1,002	740	517	469	434	366	303	197
Research & Development Expense	2,607	1,628	1,586	1,458	2,216	1,154	1,198	1,326	582	480
Other Operating Expenses / (Income)	-1.03	2.05	7.97	37	43	0.00	0.00	-	-	-
Other Special Charges / (Income)	20	29	12	15	23	20	26	7.70	17	0.00
Total Other Income / (Expense), net	255	214	-50	-15	31	85	-14	-69	-38	-43
Interest Expense	2.28	2.55	2.67	1.91	2.17	1.86	1.54	62	39	46
Interest & Investment Income	245	202	40	-24	10	34	-44	-24	1.15	7.09
Other Income / (Expense), net	13	14	-88	11	23	52	32	17	-	-4.58
Income Tax Expense	284	237	188	-378	63	40	5.85	0.85	3.18	1.03
Basic Earnings per Share	$0.16	$2.67	$1.53	$4.30	($1.36)	$2.08	$0.52	($1.53)	$0.55	$0.04
Weighted Average Basic Shares Outstanding	207.11M	223.63M	222.00M	220.43M	218.07M	214.91M	212.38M	204.58M	187.87M	179.60M
Diluted Earnings per Share	$0.15	$2.65	$1.52	$4.27	($1.36)	$2.05	$0.51	($1.53)	$0.54	$0.03
Weighted Average Diluted Shares Outstanding	210.53M	225.93M	223.96M	222.07M	218.07M	217.66M	215.64M	204.58M	194.13M	187.30M
Weighted Average Basic & Diluted Shares Outstanding	193.52M	224.53M	222.97M	221.33M	219.84M	216.78M	210.60M	204.70M	189.50M	163.30M

This table shows Incyte's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	158	201	106	-445	170	201	171	204	22	28	113
Consolidated Net Income / (Loss)	158	201	106	-445	170	201	171	204	22	28	113
Net Income / (Loss) Continuing Operations	158	201	106	-445	170	201	171	204	22	28	113
Total Pre-Tax Income	234	314	157	-390	236	271	234	278	52	81	149
Total Operating Income	205	302	146	-478	92	187	215	194	25	70	138
Total Gross Profit	980	1,090	1,052	967	820	944	859	886	752	868	769
Total Revenue	1,053	1,179	1,138	1,044	881	1,013	919	955	809	927	823
Operating Revenue	1,053	1,179	1,138	1,044	881	1,013	919	955	809	927	823
Total Cost of Revenue	73	88	86	77	61	70	60	68	57	59	55
Operating Cost of Revenue	73	88	86	77	61	70	60	68	57	59	55
Total Operating Expenses	775	789	906	1,445	728	756	644	693	727	797	630
Selling, General & Admin Expense	326	327	309	306	300	294	268	284	316	273	266
Research & Development Expense	437	466	573	1,138	429	444	376	401	407	501	384
Other Operating Expenses / (Income)	0.00	-	0.00	0.00	-1.03	2.90	1.05	-0.55	-1.36	-1.08	1.77
Other Special Charges / (Income)	12	-4.04	23	0.89	-0.46	15	-0.43	8.37	6.20	24	-22
Total Other Income / (Expense), net	29	12	10	88	144	84	19	84	27	11	10
Interest Expense	0.66	0.42	0.77	0.66	0.43	0.80	0.62	0.66	0.47	0.67	0.64
Interest & Investment Income	22	119	-13	39	100	192	-27	42	-5.32	113	-0.66
Other Income / (Expense), net	8.10	-106	24	50	45	-108	46	43	33	-101	12
Income Tax Expense	76	113	50	55	67	70	63	74	30	52	36
Basic Earnings per Share	$0.82	$0.89	$0.55	($2.04)	$0.76	$0.90	$0.76	$0.91	$0.10	$0.12	$0.51
Weighted Average Basic Shares Outstanding	193.71M	207.11M	192.63M	218.18M	224.48M	223.63M	224.08M	223.25M	222.96M	222.00M	222.42M
Diluted Earnings per Share	$0.80	$0.90	$0.54	($2.04)	$0.75	$0.89	$0.76	$0.90	$0.10	$0.13	$0.50
Weighted Average Diluted Shares Outstanding	198.20M	210.53M	195.84M	218.18M	227.22M	225.93M	226.17M	225.65M	225.59M	223.96M	224.18M
Weighted Average Basic & Diluted Shares Outstanding	193.57M	193.52M	192.65M	192.60M	224.54M	224.53M	224.11M	224.09M	223.09M	222.97M	222.48M

This table details how cash moves in and out of Incyte's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-1,526	262	894	544	-319	669	264	247	117	69
Net Cash From Operating Activities	335	496	970	749	-125	711	336	-93	305	89
Net Cash From Continuing Operating Activities	335	496	970	749	-125	711	336	-93	317	89
Net Income / (Loss) Continuing Operations	33	598	341	949	-296	447	109	-313	104	6.53
Consolidated Net Income / (Loss)	33	598	341	949	-296	447	109	-313	104	6.53
Depreciation Expense	89	83	68	58	52	55	55	52	58	45
Non-Cash Adjustments To Reconcile Net Income	141	195	293	208	168	133	193	225	100	73
Changes in Operating Assets and Liabilities, net	72	-378	268	-465	-49	77	-21	-57	55	-35
Net Cash From Investing Activities	158	-208	-79	-208	-269	-87	-86	-350	-232	-105
Net Cash From Continuing Investing Activities	158	-208	-79	-208	-269	-87	-86	-350	-232	-105
Purchase of Property, Plant & Equipment	-86	-32	-78	-181	-187	-78	-73	-111	-120	-26
Acquisitions	-14	-15	0.00	0.00	-	-	-	-	-143	0.00
Purchase of Investments	-258	-466	-80	-269	-612	-375	-169	-385	-57	-148
Sale and/or Maturity of Investments	516	306	79	242	531	365	156	146	88	69
Net Cash From Financing Activities	-2,022	-20	-0.79	6.18	72	46	15	690	45	85
Net Cash From Continuing Financing Activities	-2,022	-20	-0.79	6.18	72	46	15	690	45	85
Repurchase of Common Equity	-2,005	0.00	0.00	-	-	-	-	-	-	-
Issuance of Common Equity	49	36	61	59	133	80	30	716	50	86
Other Financing Activities, net	-66	-56	-62	-52	-61	-34	-15	-17	-4.91	0.00
Effect of Exchange Rate Changes	2.92	-6.68	3.36	-3.57	-	-	-	-	-0.01	0.00
Cash Income Taxes Paid	373	378	136	68	71	34	5.42	6.31	0.93	0.06

This table details how cash moves in and out of Incyte's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	254	384	317	-2,359	133	-14	96	310	-130	261	255
Net Cash From Operating Activities	266	381	311	-576	219	148	148	307	-106	284	296
Net Cash From Continuing Operating Activities	266	381	311	-576	219	148	148	307	-106	284	296
Net Income / (Loss) Continuing Operations	158	201	106	-445	170	201	171	204	22	28	113
Consolidated Net Income / (Loss)	158	201	106	-445	170	201	171	204	22	28	113
Depreciation Expense	22	23	23	22	22	22	21	20	19	18	17
Non-Cash Adjustments To Reconcile Net Income	68	78	83	17	-37	49	78	12	56	30	61
Changes in Operating Assets and Liabilities, net	18	80	98	-170	65	-124	-123	71	-203	207	106
Net Cash From Investing Activities	1.10	-21	38	214	-73	-155	-17	-7.43	-29	-21	-28
Net Cash From Continuing Investing Activities	1.10	-21	38	214	-73	-155	-17	-7.43	-29	-21	-28
Purchase of Property, Plant & Equipment	-3.17	-17	-5.19	-54	-9.55	-2.27	-11	-7.34	-12	-21	-28
Purchase of Investments	-41	-29	-25	-38	-166	-234	-80	-97	-55	-21	-15
Sale and/or Maturity of Investments	46	25	81	308	102	82	74	97	53	21	14
Net Cash From Financing Activities	-13	20	-32	-1,997	-12	0.35	-37	13	4.01	-2.48	-14
Net Cash From Continuing Financing Activities	-13	20	-32	-1,997	-12	0.35	-37	13	4.01	-2.48	-14
Issuance of Common Equity	3.24	33	1.28	14	0.48	7.52	-0.05	14	14	18	5.30
Other Financing Activities, net	-16	-13	-34	-6.97	-13	-7.17	-37	-1.51	-9.98	-21	-20
Effect of Exchange Rate Changes	-0.55	3.46	0.13	0.01	-0.68	-7.30	2.72	-1.89	-0.20	0.63	1.53
Cash Income Taxes Paid	0.84	70	73	227	2.69	125	116	130	7.11	20	40

This table presents Incyte's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	5,444	6,782	5,841	4,933	3,561	3,427	2,646	2,303	1,639	1,007
Total Current Assets	3,239	4,645	4,093	3,119	2,360	2,481	1,832	1,505	994	842
Cash & Equivalents	1,688	3,213	2,951	2,057	1,513	1,833	1,164	900	652	521
Short-Term Investments	470	-	288	291	288	285	274	270	156	186
Accounts Receivable	853	744	645	616	482	309	308	266	149	114
Inventories, net	59	63	42	28	16	11	6.97	6.48	4.11	1.78
Prepaid Expenses	169	183	167	126	60	44	79	62	33	18
Plant, Property, & Equipment, net	763	752	739	724	560	378	320	260	168	86
Total Noncurrent Assets	1,442	1,385	1,009	1,091	639	568	494	538	477	79
Long-Term Investments	19	188	134	221	224	135	100	135	33	49
Noncurrent Note & Lease Receivables	31	26	26	28	28	29	-	-	-	-
Goodwill	156	156	156	156	156	156	156	156	156	0.00
Intangible Assets	114	124	129	151	172	194	215	237	258	0.00
Noncurrent Deferred & Refundable Income Taxes	762	632	458	468	-	-	-	-	-	-
Other Noncurrent Operating Assets	361	261	106	68	59	55	23	10	30	30
Total Liabilities & Shareholders' Equity	5,444	6,782	5,841	4,933	3,561	3,427	2,646	2,303	1,639	1,007
Total Liabilities	1,997	1,592	1,471	1,163	950	828	720	672	1,219	836
Total Current Liabilities	1,642	1,240	1,157	854	631	513	425	375	274	168
Short-Term Debt	39	38	37	37	38	52	32	34	20	0.00
Accounts Payable	197	110	278	172	99	84	104	68	76	30
Accrued Expenses	1,212	936	701	534	378	286	229	199	127	87
Current Employee Benefit Liabilities	189	153	139	109	113	91	60	75	51	38
Other Current Liabilities	4.42	3.44	3.18	2.64	2.28	0.66	-	-	-	-
Total Noncurrent Liabilities	355	352	314	309	318	315	295	297	946	668
Other Noncurrent Operating Liabilities	355	352	314	309	318	315	277	280	294	48
Total Equity & Noncontrolling Interests	3,448	5,190	4,370	3,770	2,611	2,598	1,926	1,631	419	171
Total Preferred & Common Equity	3,448	5,190	4,370	3,770	2,611	2,598	1,926	1,631	419	171
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	3,448	5,190	4,370	3,770	2,611	2,598	1,926	1,631	419	171
Common Stock	4,534	5,016	4,792	4,567	4,353	4,045	3,814	3,628	2,097	1,951
Retained Earnings	-1,073	160	-437	-778	-1,726	-1,431	-1,878	-1,990	-1,675	-1,779
Accumulated Other Comprehensive Income / (Loss)	-13	13	15	-19	-15	-16	-10	-7.01	-2.89	-0.81
Other Equity Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-

This table presents Incyte's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	5,749	5,444	5,012	4,662	7,136	6,782	6,388	6,208	5,798	5,841	5,510
Total Current Assets	3,507	3,239	2,809	2,567	4,849	4,645	4,403	4,264	3,972	4,093	3,821
Cash & Equivalents	1,942	1,688	1,304	987	3,346	3,213	3,227	3,131	2,821	2,951	2,691
Short-Term Investments	467	470	471	532	504	-	289	292	292	288	287
Accounts Receivable	823	853	758	739	746	744	657	638	624	645	618
Inventories, net	64	59	70	101	64	63	57	36	41	42	46
Prepaid Expenses	212	169	205	208	189	183	172	167	194	167	180
Plant, Property, & Equipment, net	765	763	773	762	720	752	733	749	742	739	716
Total Noncurrent Assets	1,477	1,442	1,431	1,333	1,567	1,385	1,253	1,194	1,084	1,009	973
Long-Term Investments	17	19	28	30	288	188	154	170	128	134	151
Noncurrent Note & Lease Receivables	30	31	25	26	26	26	25	26	26	26	27
Goodwill	156	156	156	156	156	156	156	156	156	156	156
Intangible Assets	108	114	120	114	118	124	129	135	141	129	135
Noncurrent Deferred & Refundable Income Taxes	769	762	762	730	667	632	564	533	495	458	427
Other Noncurrent Operating Assets	397	361	340	279	313	261	225	175	139	106	79
Total Liabilities & Shareholders' Equity	5,749	5,444	5,012	4,662	7,136	6,782	6,388	6,208	5,798	5,841	5,510
Total Liabilities	2,082	1,997	1,841	1,665	1,741	1,592	1,457	1,468	1,335	1,471	1,284
Total Current Liabilities	1,720	1,642	1,502	1,337	1,396	1,240	1,125	1,119	1,006	1,157	1,007
Short-Term Debt	42	39	40	37	37	38	37	38	37	37	34
Accounts Payable	196	197	179	148	164	110	139	156	56	278	163
Accrued Expenses	1,376	1,212	1,128	1,034	1,102	936	821	811	825	701	700
Current Employee Benefit Liabilities	103	189	151	114	89	153	125	112	85	139	106
Other Current Liabilities	4.48	4.42	3.93	3.87	3.68	3.44	3.06	3.17	3.15	3.18	3.11
Total Noncurrent Liabilities	362	355	340	328	345	352	332	349	329	314	277
Capital Lease Obligations	33	-	28	-	29	-	29	-	30	-	30
Other Noncurrent Operating Liabilities	329	355	311	328	316	352	303	349	299	314	246
Commitments & Contingencies	0.00	-	0.00	0.00	0.00	-	0.00	-	-	-	-
Total Equity & Noncontrolling Interests	3,668	3,448	3,171	2,997	5,394	5,190	4,931	4,741	4,463	4,370	4,227
Total Preferred & Common Equity	3,668	3,448	3,171	2,997	5,394	5,190	4,931	4,741	4,463	4,370	4,227
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	3,668	3,448	3,171	2,997	5,394	5,190	4,931	4,741	4,463	4,370	4,227
Common Stock	4,588	4,534	4,430	4,383	5,071	5,016	4,949	4,926	4,857	4,792	4,721
Retained Earnings	-915	-1,073	-1,274	-1,380	330	160	-41	-212	-416	-437	-466
Accumulated Other Comprehensive Income / (Loss)	-6.24	-13	16	-5.42	-6.17	13	23	27	21	15	-29

This table displays calculated financial ratios and metrics derived from Incyte's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	14.76%	8.87%	13.67%	11.98%	23.53%	14.71%	22.50%	38.93%	46.70%	47.36%
EBITDA Growth	-77.21%	28.24%	-14.53%	446.79%	-137.09%	135.57%	224.07%	-185.56%	123.66%	148.44%
EBIT Growth	-88.31%	29.13%	-17.62%	348.02%	-152.95%	182.13%	171.16%	-256.03%	214.73%	1,058.99%
NOPAT Growth	-98.58%	19.16%	-61.70%	627.75%	-150.01%	200.88%	172.00%	-221.09%	221.38%	1,401.89%
Net Income Growth	-94.54%	75.42%	-64.09%	420.79%	-166.17%	308.16%	134.97%	-400.46%	1,495.80%	113.47%
EPS Growth	-94.34%	74.34%	-64.40%	413.97%	-166.34%	301.96%	133.33%	-383.33%	1,700.00%	110.34%
Operating Cash Flow Growth	-32.46%	-48.81%	29.41%	701.52%	-117.53%	111.36%	461.58%	-130.51%	240.86%	2.08%
Free Cash Flow Firm Growth	250.17%	-160.46%	60.74%	187.87%	-200.23%	551.64%	121.04%	-297.01%	-656.82%	73.71%
Invested Capital Growth	-28.31%	76.71%	-16.45%	98.91%	56.12%	-8.75%	15.98%	50.74%	628.66%	276.89%
Revenue Q/Q Growth	4.06%	2.40%	1.92%	2.52%	8.55%	2.42%	4.69%	8.29%	8.08%	18.92%
EBITDA Q/Q Growth	-20.10%	-1.90%	-20.52%	-7.22%	23.52%	3.40%	4,753.14%	-1,349.74%	-15.06%	1,311.22%
EBIT Q/Q Growth	-36.20%	-2.68%	-23.12%	-8.10%	19.48%	4.03%	376.40%	-228.39%	-22.89%	215.02%
NOPAT Q/Q Growth	200.79%	33.80%	-60.96%	76.30%	20.79%	1.10%	305.75%	-253.29%	-14.51%	256.14%
Net Income Q/Q Growth	0.41%	40.62%	-61.11%	77.44%	11.61%	10.36%	200.27%	-102.50%	-30.76%	107.63%
EPS Q/Q Growth	7.14%	40.21%	-61.32%	74.29%	13.38%	10.22%	204.08%	-91.25%	-32.50%	106.38%
Operating Cash Flow Q/Q Growth	229.25%	-21.49%	21.00%	139.10%	-138.02%	7.21%	106.12%	-202.57%	36.47%	-51.02%
Free Cash Flow Firm Q/Q Growth	548.26%	-306.67%	15.08%	329.19%	-396.40%	15.02%	196.31%	-108.51%	-8.32%	-81.67%
Invested Capital Q/Q Growth	-8.87%	37.69%	-11.13%	74.54%	0.00%	7.49%	21.37%	6.21%	-4.01%	28.90%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	92.64%	93.10%	93.90%	94.94%	95.08%	94.71%	95.00%	94.83%	94.74%	96.42%
EBITDA Margin	3.85%	19.40%	16.47%	21.91%	-7.07%	23.57%	11.48%	-11.33%	18.40%	12.07%
Operating Margin	1.45%	16.79%	17.07%	19.62%	-9.89%	18.62%	6.87%	-15.84%	13.11%	6.72%
EBIT Margin	1.75%	17.17%	14.47%	19.97%	-9.02%	21.04%	8.55%	-14.73%	13.11%	6.11%
Profit (Net Income) Margin	0.77%	16.17%	10.04%	31.76%	-11.09%	20.70%	5.82%	-20.38%	9.43%	0.87%
Tax Burden Percent	10.30%	71.64%	64.38%	166.29%	127.34%	91.81%	94.92%	100.27%	97.04%	86.43%
Interest Burden Percent	426.87%	131.48%	107.69%	95.64%	96.57%	107.18%	71.65%	138.04%	74.07%	16.40%
Effective Tax Rate	89.70%	28.36%	35.62%	-66.29%	0.00%	8.19%	5.08%	0.00%	2.96%	13.57%
Return on Invested Capital (ROIC)	0.40%	31.07%	32.85%	104.75%	-36.17%	88.37%	30.16%	-54.40%	99.05%	587.53%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.55%	26.50%	33.95%	105.88%	-30.86%	84.15%	31.12%	-34.34%	122.85%	687.36%
Return on Net Nonoperating Assets (RNNOA)	0.35%	-18.57%	-24.48%	-75.02%	24.81%	-68.62%	-24.01%	23.85%	-63.75%	-572.94%
Return on Equity (ROE)	0.76%	12.50%	8.37%	29.73%	-11.35%	19.76%	6.16%	-30.55%	35.29%	14.59%
Cash Return on Invested Capital (CROIC)	33.38%	-24.37%	50.77%	38.58%	-79.99%	97.53%	15.37%	-94.87%	-52.68%	-28.84%
Operating Return on Assets (OROA)	1.21%	10.05%	9.12%	14.04%	-6.88%	14.96%	6.51%	-11.48%	10.96%	5.11%
Return on Assets (ROA)	0.53%	9.47%	6.32%	22.33%	-8.46%	14.72%	4.43%	-15.89%	7.88%	0.72%
Return on Common Equity (ROCE)	0.76%	12.50%	8.37%	29.73%	-11.35%	19.76%	6.16%	-30.55%	35.29%	14.59%
Return on Equity Simple (ROE_SIMPLE)	0.95%	11.51%	7.80%	25.16%	-11.32%	17.20%	5.69%	-19.20%	24.85%	3.82%
Net Operating Profit after Tax (NOPAT)	6.32	445	373	974	-185	369	123	-170	141	44
NOPAT Margin	0.15%	12.03%	10.99%	32.62%	-6.92%	17.10%	6.52%	-11.09%	12.73%	5.81%
Net Nonoperating Expense Percent (NNEP)	0.96%	4.57%	-1.10%	-1.13%	-5.31%	4.22%	-0.96%	-20.06%	-23.80%	-99.83%
Return On Investment Capital (ROIC_SIMPLE)	0.18%	8.50%	8.47%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	7.36%	6.90%	6.10%	5.06%	4.92%	5.29%	5.00%	5.17%	5.26%	3.58%
SG&A Expenses to Revenue	29.29%	31.42%	29.52%	24.77%	19.38%	21.71%	23.08%	23.84%	27.43%	26.08%
R&D to Revenue	61.46%	44.04%	46.72%	48.83%	83.10%	53.46%	63.66%	86.32%	52.62%	63.62%
Operating Expenses to Revenue	91.20%	76.31%	76.83%	75.33%	104.96%	76.09%	88.13%	110.67%	81.62%	89.70%
Earnings before Interest and Taxes (EBIT)	74	634	491	596	-240	454	161	-226	145	46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	163	717	559	654	-189	509	216	-174	203	91
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.86	2.71	4.09	4.30	7.29	7.24	7.03	12.26	45.03	117.86
Price to Tangible Book Value (P/TBV)	4.19	2.87	4.37	4.68	8.34	8.36	8.70	16.14	3,474.23	117.86
Price to Revenue (P/Rev)	3.14	3.81	5.26	5.43	7.14	8.71	7.19	13.01	17.08	26.76
Price to Earnings (P/E)	407.98	23.55	52.45	17.09	0.00	42.09	123.59	0.00	181.24	3,088.64
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.25%	4.25%	1.91%	5.85%	0.00%	2.38%	0.81%	0.00%	0.55%	0.03%
Enterprise Value to Invested Capital (EV/IC)	8.53	5.86	14.06	11.05	27.42	41.68	27.57	49.75	74.93	584.33
Enterprise Value to Revenue (EV/Rev)	2.63	2.90	4.28	4.58	6.40	7.69	6.40	12.19	16.93	26.58
Enterprise Value to EBITDA (EV/EBITDA)	68.34	14.93	25.99	20.91	0.00	32.65	55.77	0.00	92.02	220.27
Enterprise Value to EBIT (EV/EBIT)	150.57	16.88	29.58	22.94	0.00	36.57	74.81	0.00	129.10	434.87
Enterprise Value to NOPAT (EV/NOPAT)	1,766.89	24.09	38.96	14.05	0.00	45.00	98.18	0.00	133.04	457.61
Enterprise Value to Operating Cash Flow (EV/OCF)	33.31	21.57	14.98	18.25	0.00	23.37	35.82	0.00	61.42	224.08
Enterprise Value to Free Cash Flow (EV/FCFF)	21.33	0.00	25.21	38.14	0.00	40.78	192.68	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.01	0.01	0.01	0.01	0.01	0.02	0.03	0.03	1.60	3.62
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	1.55	3.62
Financial Leverage	-0.64	-0.70	-0.72	-0.71	-0.80	-0.82	-0.77	-0.69	-0.52	-0.83
Leverage Ratio	1.42	1.32	1.32	1.33	1.34	1.34	1.39	1.92	4.48	20.15
Compound Leverage Factor	6.04	1.74	1.43	1.27	1.30	1.44	1.00	2.65	3.32	3.30
Debt to Total Capital	1.13%	0.73%	0.83%	0.97%	1.45%	1.97%	2.49%	3.02%	61.53%	78.36%
Short-Term Debt to Total Capital	1.13%	0.73%	0.83%	0.97%	1.45%	1.97%	1.61%	2.04%	1.79%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.88%	0.99%	59.74%	78.36%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	98.87%	99.27%	99.17%	99.03%	98.55%	98.03%	97.51%	96.98%	38.47%	21.64%
Debt to EBITDA	0.24	0.05	0.07	0.06	-0.20	0.10	0.23	-0.29	3.30	6.82
Net Debt to EBITDA	-13.08	-4.69	-5.97	-3.87	10.53	-4.32	-6.90	7.21	-0.84	-1.51
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.08	-0.10	3.20	6.82
Debt to NOPAT	6.21	0.09	0.10	0.04	-0.21	0.14	0.40	-0.30	4.77	14.16
Net Debt to NOPAT	-338.18	-7.56	-8.94	-2.60	10.77	-5.96	-12.14	7.36	-1.21	-3.14
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.14	-0.10	4.63	14.16
Altman Z-Score	4.90	6.79	8.65	9.70	12.46	14.80	11.84	17.57	9.36	13.70
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.97	3.75	3.54	3.65	3.74	4.83	4.31	4.01	3.64	5.01
Quick Ratio	1.83	3.19	3.36	3.47	3.62	4.73	4.11	3.83	3.50	4.89
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	524	-349	577	359	-408	407	63	-297	-75	-9.89
Operating Cash Flow to CapEx	388.74%	1,528.31%	1,246.18%	414.07%	-66.50%	910.35%	457.56%	-83.76%	253.38%	343.84%
Free Cash Flow to Firm to Interest Expense	229.62	-136.66	216.28	188.00	-187.78	219.57	40.51	-4.81	-1.93	-0.22
Operating Cash Flow to Interest Expense	147.08	194.62	363.82	392.81	-57.31	383.10	217.90	-1.51	7.87	1.96
Operating Cash Flow Less CapEx to Interest Expense	109.24	181.89	334.62	297.95	-143.50	341.02	170.28	-3.30	4.76	1.39
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.69	0.59	0.63	0.70	0.76	0.71	0.76	0.78	0.84	0.84
Accounts Receivable Turnover	5.31	5.32	5.38	5.44	6.74	7.00	6.56	7.40	8.40	8.75
Inventory Turnover	5.12	4.86	5.92	6.81	9.44	12.44	14.00	15.01	19.76	25.20
Fixed Asset Turnover	5.60	4.96	4.64	4.65	5.69	6.19	6.49	7.19	8.72	8.98
Accounts Payable Turnover	2.03	1.32	0.92	1.11	1.44	1.22	1.10	1.11	1.10	0.99
Days Sales Outstanding (DSO)	68.71	68.56	67.80	67.12	54.12	52.11	55.66	49.31	43.44	41.74
Days Inventory Outstanding (DIO)	71.26	75.13	61.63	53.58	38.67	29.34	26.08	24.31	18.47	14.49
Days Payable Outstanding (DPO)	179.57	277.09	396.44	327.40	253.49	299.47	332.53	328.98	331.47	369.08
Cash Conversion Cycle (CCC)	-39.61	-133.40	-267.01	-206.70	-160.70	-218.02	-250.79	-255.36	-269.56	-312.86
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,310	1,827	1,034	1,238	622	399	437	377	250	34
Invested Capital Turnover	2.70	2.58	2.99	3.21	5.23	5.17	4.63	4.90	7.78	101.15
Increase / (Decrease) in Invested Capital	-517	793	-204	615	224	-38	60	127	216	54
Enterprise Value (EV)	11,169	10,709	14,533	13,681	17,061	16,609	12,043	18,733	18,719	20,034
Market Capitalization	13,306	14,072	17,869	16,213	19,048	18,808	13,532	19,987	18,889	20,172
Book Value per Share	$17.90	$23.16	$19.64	$17.07	$11.92	$12.06	$9.05	$7.73	$2.23	$0.92
Tangible Book Value per Share	$16.50	$21.91	$18.36	$15.68	$10.43	$10.44	$7.31	$5.87	$0.03	$0.92
Total Capital	3,487	5,228	4,407	3,807	2,650	2,651	1,975	1,681	1,090	791
Total Debt	39	38	37	37	38	52	49	51	671	620
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	17	17	651	620
Net Debt	-2,138	-3,363	-3,336	-2,532	-1,987	-2,200	-1,489	-1,254	-170	-138
Capital Expenditures (CapEx)	86	32	78	181	187	78	73	111	120	26
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-522	230	-267	-47	-34	-97	0.50	-5.95	-68	-34
Debt-free Net Working Capital (DFNWC)	1,636	3,443	2,972	2,301	1,767	2,020	1,439	1,164	740	674
Net Working Capital (NWC)	1,597	3,405	2,936	2,264	1,729	1,968	1,407	1,129	721	674
Net Nonoperating Expense (NNE)	-26	-153	32	25	111	-78	13	143	36	37
Net Nonoperating Obligations (NNO)	-2,138	-3,363	-3,336	-2,532	-1,989	-2,200	-1,489	-1,254	-170	-137
Total Depreciation and Amortization (D&A)	89	83	68	58	52	55	55	52	58	45
Debt-free, Cash-free Net Working Capital to Revenue	-12.30%	6.23%	-7.86%	-1.57%	-1.29%	-4.50%	0.03%	-0.39%	-6.18%	-4.50%
Debt-free Net Working Capital to Revenue	38.58%	93.18%	87.56%	77.07%	66.27%	93.60%	76.46%	75.75%	66.94%	89.47%
Net Working Capital to Revenue	37.66%	92.14%	86.48%	75.83%	64.83%	91.17%	74.76%	73.52%	65.18%	89.47%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.16	$2.67	$1.53	$4.30	($1.36)	$2.08	$0.52	($1.53)	$0.55	$0.04
Adjusted Weighted Average Basic Shares Outstanding	207.11M	223.63M	222.00M	220.43M	218.07M	214.91M	212.38M	204.58M	187.87M	179.60M
Adjusted Diluted Earnings per Share	$0.15	$2.65	$1.52	$4.27	($1.36)	$2.05	$0.51	($1.53)	$0.54	$0.03
Adjusted Weighted Average Diluted Shares Outstanding	210.53M	225.93M	223.96M	222.07M	218.07M	217.66M	215.64M	204.58M	194.13M	187.30M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	193.52M	224.53M	222.97M	221.33M	219.84M	216.78M	214.05M	211.66M	189.41M	187.20M
Normalized Net Operating Profit after Tax (NOPAT)	57	465	381	420	-168	387	148	-165	158	44
Normalized NOPAT Margin	1.34%	12.59%	11.22%	14.08%	-6.31%	17.93%	7.84%	-10.74%	14.25%	5.81%
Pre Tax Income Margin	7.47%	22.57%	15.59%	19.10%	-8.71%	22.55%	6.13%	-20.33%	9.71%	1.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	32.53	248.71	184.30	312.59	-110.61	244.85	104.33	-3.66	3.74	1.01
NOPAT to Interest Expense	2.77	174.25	139.93	510.52	-84.90	198.96	79.50	-2.76	3.63	0.96
EBIT Less CapEx to Interest Expense	-5.30	235.98	155.10	217.72	-196.80	202.76	56.71	-5.46	0.64	0.44
NOPAT Less CapEx to Interest Expense	-35.06	161.52	110.74	415.66	-171.09	156.88	31.87	-4.55	0.53	0.39
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	6,146.83%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Incyte's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	19.53%	16.32%	23.81%	9.34%	8.93%	9.35%	11.63%	4.74%	10.29%	7.40%	1.27%
EBITDA Growth	110.72%	116.07%	-31.74%	-258.26%	106.35%	871.82%	69.57%	-5.42%	-42.75%	-109.97%	-33.91%
EBIT Growth	137.30%	146.70%	-34.78%	-281.17%	137.05%	353.24%	74.18%	-7.26%	-51.07%	-126.89%	-36.85%
NOPAT Growth	110.07%	39.15%	-36.83%	-335.56%	536.43%	461.60%	49.76%	-20.65%	-83.48%	-95.24%	-48.58%
Net Income Growth	-6.69%	0.07%	-37.84%	-318.43%	681.22%	606.51%	51.87%	26.09%	-42.87%	-94.95%	-37.95%
EPS Growth	6.67%	1.12%	-28.95%	-326.67%	650.00%	584.62%	52.00%	25.00%	-41.18%	-94.88%	-39.02%
Operating Cash Flow Growth	21.60%	158.05%	110.28%	-287.77%	307.20%	-47.92%	-50.12%	76.01%	-148.95%	145.91%	16.18%
Free Cash Flow Firm Growth	347.30%	208.62%	-78.40%	-408.88%	148.86%	-386.56%	98.21%	151.87%	87.90%	339.92%	30.78%
Invested Capital Growth	-0.47%	-28.31%	8.33%	25.38%	2.61%	76.71%	14.06%	-5.10%	6.32%	-16.45%	64.09%
Revenue Q/Q Growth	-10.67%	3.59%	9.02%	18.49%	-13.07%	10.26%	-3.73%	18.05%	-12.74%	12.56%	-9.67%
EBITDA Q/Q Growth	7.91%	13.25%	147.45%	-356.21%	-38.88%	-64.22%	10.02%	234.07%	-33.14%	-107.86%	-38.64%
EBIT Q/Q Growth	9.02%	14.88%	139.75%	-413.49%	-42.52%	-69.63%	10.42%	310.19%	-40.41%	-120.89%	-41.21%
NOPAT Q/Q Growth	-28.33%	94.63%	129.69%	-607.28%	-52.53%	-11.64%	10.70%	1,270.58%	-58.11%	-76.44%	-41.35%
Net Income Q/Q Growth	-21.38%	89.01%	123.94%	-362.23%	-15.68%	17.41%	-15.86%	837.88%	-23.74%	-74.76%	-30.14%
EPS Q/Q Growth	-11.11%	66.67%	126.47%	-372.00%	-15.73%	17.11%	-15.56%	800.00%	-23.08%	-74.00%	-30.56%
Operating Cash Flow Q/Q Growth	-30.21%	22.63%	154.01%	-363.04%	48.12%	-0.07%	-51.77%	390.26%	-137.23%	-4.29%	70.18%
Free Cash Flow Firm Q/Q Growth	-79.62%	6,465.65%	98.24%	-2,062.49%	115.31%	-10,354.65%	-103.04%	410.45%	-129.02%	165.33%	11.88%
Invested Capital Q/Q Growth	0.45%	-8.87%	-3.21%	12.34%	-4.51%	37.69%	12.03%	-8.06%	24.60%	-11.13%	-6.78%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	93.05%	92.49%	92.44%	92.66%	93.08%	93.12%	93.46%	92.84%	92.97%	93.62%	93.37%
EBITDA Margin	22.38%	18.52%	16.94%	-38.93%	18.00%	9.97%	30.74%	26.90%	9.50%	-1.41%	20.23%
Operating Margin	19.49%	25.58%	12.84%	-45.81%	10.43%	18.48%	23.36%	20.30%	3.06%	7.56%	16.81%
EBIT Margin	20.26%	16.60%	14.96%	-41.04%	15.51%	7.82%	28.41%	24.77%	7.13%	-3.38%	18.21%
Profit (Net Income) Margin	15.03%	17.07%	9.36%	-42.60%	19.25%	19.84%	18.64%	21.32%	2.68%	3.07%	13.70%
Tax Burden Percent	67.55%	64.14%	68.01%	114.07%	71.79%	74.21%	73.25%	73.32%	41.85%	35.30%	75.90%
Interest Burden Percent	109.81%	160.38%	91.92%	90.99%	172.83%	341.72%	89.55%	117.41%	89.96%	-257.47%	99.13%
Effective Tax Rate	32.45%	35.86%	31.99%	0.00%	28.21%	25.79%	26.75%	26.68%	58.15%	64.70%	24.10%
Return on Invested Capital (ROIC)	44.05%	44.36%	25.75%	-92.65%	21.62%	35.43%	49.60%	42.99%	3.56%	7.98%	45.38%
ROIC Less NNEP Spread (ROIC-NNEP)	43.44%	44.08%	25.48%	-88.32%	18.76%	33.57%	49.18%	41.07%	3.17%	7.85%	45.10%
Return on Net Nonoperating Assets (RNNOA)	-30.79%	-28.07%	-16.79%	57.85%	-13.79%	-23.53%	-35.81%	-29.75%	-2.22%	-5.66%	-33.65%
Return on Equity (ROE)	13.25%	16.29%	8.96%	-34.81%	7.83%	11.90%	13.79%	13.24%	1.34%	2.32%	11.73%
Cash Return on Invested Capital (CROIC)	1.37%	33.38%	-8.45%	-22.20%	35.99%	-24.37%	13.55%	28.26%	18.66%	50.77%	53.52%
Operating Return on Assets (OROA)	13.88%	11.51%	10.70%	-29.12%	9.04%	4.58%	17.23%	15.10%	4.56%	-2.13%	12.49%
Return on Assets (ROA)	10.29%	11.84%	6.69%	-30.23%	11.21%	11.62%	11.31%	13.00%	1.72%	1.94%	9.40%
Return on Common Equity (ROCE)	13.25%	16.29%	8.96%	-34.81%	7.83%	11.90%	13.79%	13.24%	1.34%	2.32%	11.73%
Return on Equity Simple (ROE_SIMPLE)	0.58%	0.00%	1.02%	3.25%	13.82%	0.00%	8.62%	7.73%	7.27%	0.00%	20.73%
Net Operating Profit after Tax (NOPAT)	139	193	99	-335	66	139	157	142	10	25	105
NOPAT Margin	13.16%	16.41%	8.73%	-32.07%	7.49%	13.71%	17.11%	14.88%	1.28%	2.67%	12.76%
Net Nonoperating Expense Percent (NNEP)	0.61%	0.28%	0.27%	-4.34%	2.86%	1.85%	0.42%	1.92%	0.39%	0.13%	0.28%
Return On Investment Capital (ROIC_SIMPLE)	3.70%	5.55%	-	-	-	2.66%	-	-	-	0.56%	-
Cost of Revenue to Revenue	6.95%	7.51%	7.56%	7.34%	6.92%	6.88%	6.54%	7.16%	7.03%	6.38%	6.63%
SG&A Expenses to Revenue	30.93%	27.72%	27.17%	29.32%	34.09%	29.00%	29.15%	29.74%	39.03%	29.44%	32.36%
R&D to Revenue	41.53%	39.54%	50.37%	109.07%	48.73%	43.86%	40.88%	41.98%	50.29%	54.10%	46.64%
Operating Expenses to Revenue	73.56%	66.91%	79.60%	138.47%	82.65%	74.64%	70.10%	72.54%	89.91%	86.05%	76.56%
Earnings before Interest and Taxes (EBIT)	213	196	170	-428	137	79	261	236	58	-31	150
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	236	218	193	-406	159	101	282	257	77	-13	167
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.20	3.86	4.01	4.54	0.00	2.71	2.63	2.93	3.61	4.09	3.51
Price to Tangible Book Value (P/TBV)	3.44	4.19	4.40	4.99	0.00	2.87	2.79	3.12	3.87	4.37	3.77
Price to Revenue (P/Rev)	2.66	3.14	3.12	3.53	0.00	3.81	3.59	3.95	4.64	5.26	4.45
Price to Earnings (P/E)	550.91	407.98	391.93	139.90	0.00	23.55	30.46	37.89	49.68	52.45	16.92
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.18%	0.25%	0.26%	0.71%	0.00%	4.25%	3.28%	2.64%	2.01%	1.91%	5.91%
Enterprise Value to Invested Capital (EV/IC)	7.12	8.53	7.65	8.15	0.00	5.86	7.04	8.72	10.04	14.06	10.11
Enterprise Value to Revenue (EV/Rev)	2.12	2.63	2.70	3.14	0.00	2.90	2.59	2.94	3.73	4.28	3.53
Enterprise Value to EBITDA (EV/EBITDA)	32.61	68.34	53.76	41.13	0.00	14.93	12.78	16.80	20.54	25.99	16.71
Enterprise Value to EBIT (EV/EBIT)	47.41	150.57	94.58	58.44	0.00	16.88	14.33	19.11	23.14	29.58	18.40
Enterprise Value to NOPAT (EV/NOPAT)	793.42	1,766.89	0.00	2,773.80	0.00	24.09	28.12	36.88	41.75	38.96	12.31
Enterprise Value to Operating Cash Flow (EV/OCF)	24.48	33.31	107.98	0.00	0.00	21.57	14.77	13.23	19.95	14.98	14.67
Enterprise Value to Free Cash Flow (EV/FCFF)	519.86	21.33	0.00	0.00	0.00	0.00	55.37	30.06	55.47	25.21	23.47
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.02	0.01	0.02	0.01	0.01	0.01	0.01	0.01	0.02	0.01	0.02
Long-Term Debt to Equity	0.01	0.00	0.01	0.00	0.01	0.00	0.01	0.00	0.01	0.00	0.01
Financial Leverage	-0.71	-0.64	-0.66	-0.66	-0.74	-0.70	-0.73	-0.72	-0.70	-0.72	-0.75
Leverage Ratio	1.42	1.42	1.41	1.40	1.31	1.32	1.30	1.31	1.30	1.32	1.32
Compound Leverage Factor	1.56	2.27	1.29	1.28	2.27	4.51	1.16	1.53	1.17	-3.41	1.31
Debt to Total Capital	1.99%	1.13%	2.12%	1.22%	1.21%	0.73%	1.31%	0.79%	1.48%	0.83%	1.51%
Short-Term Debt to Total Capital	1.11%	1.13%	1.25%	1.22%	0.68%	0.73%	0.74%	0.79%	0.82%	0.83%	0.80%
Long-Term Debt to Total Capital	0.87%	0.00%	0.87%	0.00%	0.53%	0.00%	0.58%	0.00%	0.66%	0.00%	0.71%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	98.01%	98.87%	97.88%	98.78%	98.79%	99.27%	98.69%	99.22%	98.52%	99.17%	98.49%
Debt to EBITDA	0.26	0.24	0.34	0.13	0.07	0.05	0.09	0.06	0.11	0.07	0.09
Net Debt to EBITDA	-8.19	-13.08	-8.48	-5.14	-4.25	-4.69	-4.93	-5.78	-5.04	-5.97	-4.35
Long-Term Debt to EBITDA	0.11	0.00	0.14	0.00	0.03	0.00	0.04	0.00	0.05	0.00	0.04
Debt to NOPAT	6.30	6.21	-10.93	8.52	0.13	0.09	0.20	0.13	0.22	0.10	0.07
Net Debt to NOPAT	-199.22	-338.18	276.44	-346.59	-8.09	-7.56	-10.85	-12.69	-10.24	-8.94	-3.21
Long-Term Debt to NOPAT	2.77	0.00	-4.50	0.00	0.06	0.00	0.09	0.00	0.10	0.00	0.03
Altman Z-Score	4.42	4.97	5.03	5.33	0.00	6.52	6.64	6.93	8.39	8.35	8.12
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.04	1.97	1.87	1.92	3.47	3.75	3.91	3.81	3.95	3.54	3.80
Quick Ratio	1.88	1.83	1.69	1.69	3.29	3.19	3.71	3.63	3.71	3.36	3.57
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	145	711	-11	-635	32	-654	-6.26	206	-66	228	-349
Operating Cash Flow to CapEx	8,395.93%	2,192.92%	5,993.27%	-1,063.04%	2,291.45%	6,516.50%	1,346.89%	4,177.81%	-886.97%	1,333.44%	1,065.70%
Free Cash Flow to Firm to Interest Expense	219.41	1,695.91	-14.42	-967.04	75.29	-813.65	-10.04	314.03	-141.27	342.25	-545.11
Operating Cash Flow to Interest Expense	403.13	909.83	401.64	-876.05	508.86	183.74	237.30	467.98	-225.17	425.28	462.37
Operating Cash Flow Less CapEx to Interest Expense	398.33	868.34	394.94	-958.46	486.66	180.92	219.68	456.78	-250.55	393.39	418.99
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.69	0.69	0.72	0.71	0.58	0.59	0.61	0.61	0.64	0.63	0.69
Accounts Receivable Turnover	5.63	5.31	5.76	5.60	5.50	5.32	5.66	5.32	5.85	5.38	5.87
Inventory Turnover	5.08	5.12	4.60	3.91	4.96	4.86	4.74	5.28	5.80	5.92	5.71
Fixed Asset Turnover	5.94	5.60	5.41	5.10	5.16	4.96	4.98	4.78	4.72	4.64	4.75
Accounts Payable Turnover	1.80	2.03	1.84	1.76	2.36	1.32	1.62	1.36	2.13	0.92	1.38
Days Sales Outstanding (DSO)	64.87	68.71	63.39	65.16	66.32	68.56	64.50	68.62	62.38	67.80	62.18
Days Inventory Outstanding (DIO)	71.82	71.26	79.41	93.25	73.61	75.13	76.96	69.09	62.98	61.63	63.95
Days Payable Outstanding (DPO)	202.46	179.57	197.92	207.26	154.85	277.09	225.95	267.61	171.75	396.44	264.35
Cash Conversion Cycle (CCC)	-65.78	-39.61	-55.12	-48.86	-14.92	-133.40	-84.49	-129.90	-46.40	-267.01	-138.22
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,316	1,310	1,438	1,485	1,322	1,827	1,327	1,185	1,288	1,034	1,163
Invested Capital Turnover	3.35	2.70	2.95	2.89	2.89	2.58	2.90	2.89	2.78	2.99	3.56
Increase / (Decrease) in Invested Capital	-6.21	-517	111	301	34	793	164	-64	77	-204	454
Enterprise Value (EV)	9,366	11,169	10,997	12,100	0.00	10,709	9,341	10,331	12,940	14,533	11,760
Market Capitalization	11,718	13,306	12,731	13,612	0.00	14,072	12,946	13,887	16,114	17,869	14,823
Book Value per Share	$18.95	$17.90	$16.47	$13.35	$24.03	$23.16	$22.01	$21.25	$20.01	$19.64	$19.00
Tangible Book Value per Share	$17.59	$16.50	$15.03	$12.15	$22.81	$21.91	$20.74	$19.95	$18.69	$18.36	$17.70
Total Capital	3,742	3,487	3,240	3,034	5,460	5,228	4,997	4,778	4,529	4,407	4,291
Total Debt	74	39	69	37	66	38	66	38	67	37	65
Total Long-Term Debt	33	0.00	28	0.00	29	0.00	29	0.00	30	0.00	30
Net Debt	-2,352	-2,138	-1,734	-1,512	-4,072	-3,363	-3,604	-3,556	-3,174	-3,336	-3,063
Capital Expenditures (CapEx)	3.17	17	5.19	54	9.55	2.27	11	7.34	12	21	28
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-580	-522	-427	-252	-361	230	-202	-240	-110	-267	-128
Debt-free Net Working Capital (DFNWC)	1,829	1,636	1,347	1,267	3,490	3,443	3,315	3,183	3,003	2,972	2,849
Net Working Capital (NWC)	1,787	1,597	1,307	1,230	3,453	3,405	3,278	3,146	2,966	2,936	2,815
Net Nonoperating Expense (NNE)	-20	-7.83	-7.10	110	-104	-62	-14	-61	-11	-3.71	-7.75
Net Nonoperating Obligations (NNO)	-2,352	-2,138	-1,734	-1,512	-4,072	-3,363	-3,604	-3,556	-3,174	-3,336	-3,063
Total Depreciation and Amortization (D&A)	22	23	23	22	22	22	21	20	19	18	17
Debt-free, Cash-free Net Working Capital to Revenue	-13.14%	-12.30%	-10.48%	-6.54%	-9.58%	6.23%	-5.59%	-6.84%	-3.17%	-7.86%	-3.86%
Debt-free Net Working Capital to Revenue	41.44%	38.58%	33.06%	32.85%	92.62%	93.18%	91.85%	90.60%	86.53%	87.56%	85.53%
Net Working Capital to Revenue	40.49%	37.66%	32.07%	31.89%	91.63%	92.14%	90.83%	89.54%	85.46%	86.48%	84.50%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.82	$0.89	$0.55	($2.04)	$0.76	$0.90	$0.76	$0.91	$0.10	$0.12	$0.51
Adjusted Weighted Average Basic Shares Outstanding	193.71M	207.11M	192.63M	218.18M	224.48M	223.63M	224.08M	223.25M	222.96M	222.00M	222.42M
Adjusted Diluted Earnings per Share	$0.80	$0.90	$0.54	($2.04)	$0.75	$0.89	$0.76	$0.90	$0.10	$0.13	$0.50
Adjusted Weighted Average Diluted Shares Outstanding	198.20M	210.53M	195.84M	218.18M	227.22M	225.93M	226.17M	225.65M	225.59M	223.96M	224.18M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	193.57M	193.52M	192.65M	192.60M	224.54M	224.53M	224.11M	224.09M	223.09M	222.97M	222.48M
Normalized Net Operating Profit after Tax (NOPAT)	146	191	115	-334	66	150	157	148	22	66	88
Normalized NOPAT Margin	13.91%	16.19%	10.13%	-32.01%	7.45%	14.82%	17.08%	15.53%	2.68%	7.13%	10.74%
Pre Tax Income Margin	22.24%	26.62%	13.76%	-37.34%	26.81%	26.74%	25.44%	29.08%	6.41%	8.70%	18.05%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	323.13	466.86	220.00	-652.00	317.77	98.62	419.06	360.99	122.91	-46.94	233.84
NOPAT to Interest Expense	210.00	461.53	128.37	-509.42	153.44	172.85	252.46	216.92	22.10	37.10	163.84
EBIT Less CapEx to Interest Expense	318.33	425.37	213.30	-734.40	295.57	95.80	401.44	349.79	97.52	-78.84	190.45
NOPAT Less CapEx to Interest Expense	205.20	420.04	121.67	-591.83	131.23	170.03	234.84	205.72	-3.28	5.21	120.46
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	6,146.83%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Incyte's Financials

When does Incyte's fiscal year end?

According to the most recent income statement we have on file, Incyte's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Incyte's net income changed over the last 9 years?

Incyte's net income appears to be on an upward trend, with a most recent value of $32.62 million in 2024, rising from $6.53 million in 2015. The previous period was $597.60 million in 2023. Find out what analysts predict for Incyte in the coming months.

What is Incyte's operating income?

Incyte's total operating income in 2024 was $61.37 million, based on the following breakdown:

Total Gross Profit: $3.93 billion
Total Operating Expenses: $3.87 billion

How has Incyte revenue changed over the last 9 years?

Over the last 9 years, Incyte's total revenue changed from $753.75 million in 2015 to $4.24 billion in 2024, a change of 462.7%.

How much debt does Incyte have?

Incyte's total liabilities were at $2.00 billion at the end of 2024, a 25.4% increase from 2023, and a 138.8% increase since 2015.

How much cash does Incyte have?

In the past 9 years, Incyte's cash and equivalents has ranged from $521.44 million in 2015 to $3.21 billion in 2023, and is currently $1.69 billion as of their latest financial filing in 2024.

How has Incyte's book value per share changed over the last 9 years?

Over the last 9 years, Incyte's book value per share changed from 0.92 in 2015 to 17.90 in 2024, a change of 1,844.8%.

Related Companies

This page (NASDAQ:INCY) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Incyte (INCY) Financials

Frequently Asked Questions About Incyte's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Incyte (INCY) Financials

Annual Income Statements for Incyte

Quarterly Income Statements for Incyte

Annual Cash Flow Statements for Incyte

Quarterly Cash Flow Statements for Incyte

Annual Balance Sheets for Incyte

Quarterly Balance Sheets for Incyte

Annual Metrics And Ratios for Incyte

Quarterly Metrics And Ratios for Incyte

Frequently Asked Questions About Incyte's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools